{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:07:40Z","timestamp":1791162460648,"version":"4.1.0"},"reference-count":59,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,4,1]]},"DOI":"10.1210\/me.2002-0318","type":"journal-article","created":{"date-parts":[[2003,3,26]],"date-time":"2003-03-26T20:44:36Z","timestamp":1048711476000},"page":"575-588","source":"Crossref","is-referenced-by-count":195,"title":["Insulin-Like Growth Factor-I Inhibits Progesterone Receptor Expression in Breast Cancer Cells via the Phosphatidylinositol 3-Kinase\/Akt\/Mammalian Target of Rapamycin Pathway: Progesterone Receptor as a Potential Indicator of Growth Factor Activity in Breast Cancer"],"prefix":"10.1210","volume":"17","author":[{"given":"Xiaojiang","family":"Cui","sequence":"first","affiliation":[{"name":"Breast Center (X.C., P.Z., W.D., S.O., A.V.L.), Baylor College of Medicine; Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Breast Center (X.C., P.Z., W.D., S.O., A.V.L.), Baylor College of Medicine; Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanleng","family":"Deng","sequence":"additional","affiliation":[{"name":"Breast Center (X.C., P.Z., W.D., S.O., A.V.L.), Baylor College of Medicine; Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Oesterreich","sequence":"additional","affiliation":[{"name":"Breast Center (X.C., P.Z., W.D., S.O., A.V.L.), Baylor College of Medicine; Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Molecular Therapeutics (Y.L., G.B.M.), University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Molecular Therapeutics (Y.L., G.B.M.), University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.","family":"Lee","sequence":"additional","affiliation":[{"name":"Breast Center (X.C., P.Z., W.D., S.O., A.V.L.), Baylor College of Medicine; Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041123442614100_R1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0950-351X(96)80298-9","article-title":"Insulin-like growth factor receptors and binding proteins.","volume":"10","author":"LeRoith","year":"1996","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"2019041123442614100_R2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<828::AID-IJC20>3.0.CO;2-3","article-title":"Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.","volume":"72","author":"Nolan","year":"1997","journal-title":"Int J Cancer"},{"key":"2019041123442614100_R3","first-page":"249","article-title":"The insulin-like growth factor I receptor: a key to tumor growth?","volume":"55","author":"Baserga","year":"1995","journal-title":"Cancer Res"},{"key":"2019041123442614100_R4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0167-7799(96)10023-8","article-title":"Controlling IGF-receptor function: a possible strategy for tumor therapy.","volume":"14","author":"Baserga","year":"1996","journal-title":"Trends Biotechnol"},{"key":"2019041123442614100_R5","first-page":"3651","article-title":"Pregnancy-dependent growth of mammary tumors is associated with overexpression of insulin-like growth factor II.","volume":"56","author":"Huynh","year":"1996","journal-title":"Cancer Res"},{"key":"2019041123442614100_R6","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1210\/endo.140.11.7095","article-title":"Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.","volume":"140","author":"Ruan","year":"1999","journal-title":"Endocrinology"},{"key":"2019041123442614100_R7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0753-3322(96)82678-3","article-title":"Insulin-like growth factors and breast cancer.","volume":"49","author":"Lee","year":"1995","journal-title":"Biomed Pharmacother"},{"key":"2019041123442614100_R8","first-page":"4083","article-title":"Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17\u03b2-estradiol.","volume":"48","author":"Karey","year":"1988","journal-title":"Cancer Res"},{"key":"2019041123442614100_R9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1172\/JCI114315","article-title":"Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.","volume":"84","author":"Arteaga","year":"1989","journal-title":"J Clin Invest"},{"key":"2019041123442614100_R10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00666209","article-title":"The insulin-like growth factor system as a target in breast cancer.","volume":"32","author":"Yee","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2019041123442614100_R11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"2019041123442614100_R12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1005915420341","article-title":"IGF system components as prognostic markers in breast cancer.","volume":"47","author":"Lee","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"2019041123442614100_R13","first-page":"428","article-title":"Hormone receptors: their role in predicting prognosis and response to endocrine therapy.","volume":"5","author":"McGuire","year":"1978","journal-title":"Semin Oncol"},{"key":"2019041123442614100_R14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/edrv-11-2-266","article-title":"Progestin regulation of cellular proliferation.","volume":"11","author":"Clarke","year":"1990","journal-title":"Endocr Rev"},{"key":"2019041123442614100_R15","first-page":"502","article-title":"Physiological action of progesterone in target tissues.","volume":"18","author":"Graham","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041123442614100_R16","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1101\/gad.9.18.2266","article-title":"Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.","volume":"9","author":"Lydon","year":"1995","journal-title":"Genes Dev"},{"key":"2019041123442614100_R17","first-page":"146","article-title":"The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?","volume":"13","author":"Horwitz","year":"1992","journal-title":"Endocr Rev"},{"key":"2019041123442614100_R18","doi-asserted-by":"crossref","first-page":"8348","DOI":"10.1021\/bi00083a039","article-title":"Activation of the silent progesterone receptor gene by ectopic expression of estrogen receptors in a rat fibroblast cell line.","volume":"32","author":"Kaneko","year":"1993","journal-title":"Biochemistry"},{"key":"2019041123442614100_R19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0092-8674(82)90218-5","article-title":"Variant T47D human breast cancer cells with high progesterone receptor levels despite estrogen and antiestrogen resistance.","volume":"28","author":"Horwitz,","year":"1982","journal-title":"Cell"},{"key":"2019041123442614100_R20","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.","volume":"9","author":"Kastner","year":"1990","journal-title":"EMBO J"},{"key":"2019041123442614100_R21","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/MCB.11.10.5032","article-title":"Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor \u03b1, epidermal growth factor receptor, c-fos, and c-myc genes.","volume":"11","author":"Musgrove","year":"1991","journal-title":"Mol Cell Biol"},{"key":"2019041123442614100_R22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/mend.11.11.0006","article-title":"Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).","volume":"11","author":"Groshong","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041123442614100_R23","first-page":"395","article-title":"Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA.","volume":"5","author":"Lin","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2019041123442614100_R24","doi-asserted-by":"crossref","first-page":"31308","DOI":"10.1074\/jbc.273.47.31308","article-title":"Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways.","volume":"273","author":"Lange","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041123442614100_R25","doi-asserted-by":"crossref","first-page":"31317","DOI":"10.1074\/jbc.273.47.31317","article-title":"Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity.","volume":"273","author":"Richer","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041123442614100_R26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1018778403001","article-title":"The loss of estrogen and progesterone receptor gene expression in human breast cancer.","volume":"3","author":"Lapidus","year":"1998","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2019041123442614100_R27","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/sj.bjc.6690249","article-title":"Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.","volume":"79","author":"Balleine","year":"1999","journal-title":"Br J Cancer"},{"key":"2019041123442614100_R28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000063434","article-title":"Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors.","volume":"54","author":"Bamberger","year":"2000","journal-title":"Horm Res"},{"key":"2019041123442614100_R29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer.","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"2019041123442614100_R30","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1038\/sj.onc.1203973","article-title":"Molecular mechanisms underlying ErbB2\/HER2 action in breast cancer.","volume":"19","author":"Harari","year":"2000","journal-title":"Oncogene"},{"key":"2019041123442614100_R31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/mp.54.3.149","article-title":"Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects.","volume":"54","author":"Dupont","year":"2001","journal-title":"Mol Pathol"},{"key":"2019041123442614100_R32","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1073\/pnas.97.3.1032","article-title":"Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.","volume":"97","author":"Lange","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123442614100_R33","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/MCB.20.5.1489-1496.2000","article-title":"Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3\u2032-kinase inhibition.","volume":"20","author":"Lee","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2019041123442614100_R34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ijc.2910590310","article-title":"Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.","volume":"59","author":"Nagai","journal-title":"Int J Cancer"},{"key":"2019041123442614100_R35","first-page":"5771","article-title":"Re-expression of estrogen receptor \u03b1 in estrogen receptor \u03b1-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.","volume":"61","author":"Oesterreich","year":"2001","journal-title":"Cancer Res"},{"key":"2019041123442614100_R36","first-page":"3504","article-title":"A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.","volume":"60","author":"Sekulic","year":"2000","journal-title":"Cancer Res"},{"key":"2019041123442614100_R37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0303-7207(96)04016-6","article-title":"Insulin-like growth factors control the regulation of oestrogen and progesterone receptor expression by oestrogens.","volume":"128","author":"Clayton","year":"1997","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123442614100_R38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/(SICI)1097-4644(20000315)76:4<605::AID-JCB9>3.0.CO;2-T","article-title":"Role of insulin-like growth factor-I in regulating estrogen receptor-\u03b1 gene expression.","volume":"76","author":"Stoica","year":"2000","journal-title":"J Cell Biochem"},{"key":"2019041123442614100_R39","first-page":"743","article-title":"Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.","volume":"7","author":"Aronica","year":"1993","journal-title":"Mol Endocrinol"},{"key":"2019041123442614100_R40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1677\/joe.0.1520039","article-title":"Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.","volume":"152","author":"Lee","year":"1997","journal-title":"J Endocrinol"},{"key":"2019041123442614100_R41","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1074\/jbc.M109592200","article-title":"Requirement of estrogen receptor-\u03b1 in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1\/estrogen receptor cross-talk.","volume":"277","author":"Klotz","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041123442614100_R42","doi-asserted-by":"crossref","first-page":"24353","DOI":"10.1074\/jbc.M201829200","article-title":"Opposing action of estrogen receptors \u03b1 and \u03b2 on cyclin D1 gene expression.","volume":"277","author":"Liu","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041123442614100_R43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/excr.2001.5430","article-title":"Synergistic proliferative action of insulin-like growth factor I and 17 \u03b2-estradiol in MCF-7S breast tumor cells.","volume":"273","author":"Hamelers","year":"2002","journal-title":"Exp Cell Res"},{"key":"2019041123442614100_R44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1677\/joe.0.1660329","article-title":"Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells.","volume":"166","author":"Dufourny","year":"2000","journal-title":"J Endocrinol"},{"key":"2019041123442614100_R45","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1210\/endo.141.12.7836","article-title":"A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I.","volume":"141","author":"Martin","year":"2000","journal-title":"Endocrinology"},{"key":"2019041123442614100_R46","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1074\/jbc.M010840200","article-title":"Phosphatidylinositol 3-kinase\/AKT-mediated activation of estrogen receptor \u03b1: a new model for anti-estrogen resistance.","volume":"276","author":"Campbell","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041123442614100_R47","first-page":"669","volume":"66","author":"Potapova"},{"key":"2019041123442614100_R48","first-page":"3924","article-title":"Insulin receptor expression and function in human breast cancer cell lines.","volume":"52","author":"Milazzo","year":"1992","journal-title":"Cancer Res"},{"key":"2019041123442614100_R49","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1073\/pnas.83.3.664","article-title":"Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts.","volume":"83","author":"Flier","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123442614100_R50","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/endo.134.2.7507831","article-title":"Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3\u2032,5\u2032-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.","volume":"134","author":"Cho","year":"1994","journal-title":"Endocrinology"},{"key":"2019041123442614100_R51","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1210\/endo.142.7.8259","article-title":"Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).","volume":"142","author":"McClelland","year":"2001","journal-title":"Endocrinology"},{"key":"2019041123442614100_R52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/dbio.2002.0625","article-title":"Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population.","volume":"245","author":"Welm","year":"2002","journal-title":"Dev Biol"},{"key":"2019041123442614100_R53","first-page":"8452","article-title":"HER-2 amplification impedes the antiproliferative effectsof hormone therapy in estrogen receptor-positive primary breast cancer.","volume":"61","author":"Dowsett","year":"2001","journal-title":"Cancer Res"},{"key":"2019041123442614100_R54","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1128\/MCB.21.18.6122-6131.2001","article-title":"Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.","volume":"21","author":"Shen","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2019041123442614100_R55","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/j.1460-2075.1996.tb00602.x","article-title":"Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.","volume":"15","author":"Rodriguez-Viciana","year":"1996","journal-title":"EMBO J"},{"key":"2019041123442614100_R56","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1074\/jbc.M109870200","article-title":"Insulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activity.","volume":"277","author":"Patel","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041123442614100_R57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01807363","article-title":"Biological differences among MCF-7 human breast cancer cell lines from different laboratories.","volume":"9","author":"Osborne","year":"1987","journal-title":"Breast Cancer Res Treat"},{"key":"2019041123442614100_R58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0092-8674(95)90534-0","article-title":"The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.","volume":"81","author":"Franke","year":"1995","journal-title":"Cell"},{"key":"2019041123442614100_R59","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1074\/jbc.M110090200","article-title":"Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells.","volume":"277","author":"Richer","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/17\/4\/575\/8965937\/mend0575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T14:42:11Z","timestamp":1555080131000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/17\/4\/575\/2756342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2002-0318","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,1]]}}}